Satellos Bioscience
MSLE
31 hedge funds and large institutions have $42.8M invested in Satellos Bioscience in 2026 Q1 according to their latest regulatory filings, with 31 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
36.83% more ownership
Funds ownership: 0% → 36.83% (+37%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Franklin Resources
San Mateo,
California
|
+$9.22M |
| 2 |
SL
Siren LLC
Greenwich,
Connecticut
|
+$8.76M |
| 3 |
VC
Vivo Capital
Palo Alto,
California
|
+$7.99M |
| 4 |
Point72 Asset Management
Stamford,
Connecticut
|
+$6.79M |
| 5 |
WP
Woodline Partners
San Francisco,
California
|
+$4.92M |
Top Sellers
MSLE Hedge Fund Activity: Q1 2026 in Review
31 of the 8,208 institutional investors tracked by Wall St. Rank reported a position in Satellos Bioscience (MSLE) for Q1 2026, worth a combined $42.8M.
Buyers outnumbered sellers: 31 funds opened new MSLE positions and 0 closed out — a net gain of 31 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was Franklin Resources, opening a new position worth an estimated $9.22M.
- 31 institutional investors held Satellos Bioscience (MSLE) as of Q1 2026, up from 0 in Q4 2025.
- Funds reported $42.8M of Satellos Bioscience stock for Q1 2026.
- 31 funds opened new Satellos Bioscience positions in Q1 2026 and 0 closed out, a net change of +31 holders.
- The largest Satellos Bioscience buyer in Q1 2026 was Franklin Resources, an estimated $9.22M added.
Based on aggregated 13F filings for Q1 2026.